Serum potassium in the PARADIGM‐HF trial-Reference-Cited by-同舟云学术

Serum potassium in the PARADIGM‐HF trial

Published:2020-09-29 Issue:11 Volume:22 Page:2056-2064
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Ferreira João Pedro¹²,Mogensen Ulrik M.³,Jhund Pardeep S.²,Desai Akshay S.⁴,Rouleau Jean‐Lucien⁵,Zile Michael R.⁶,Rossignol Patrick¹,Zannad Faiez¹,Packer Milton⁷,Solomon Scott D.⁴,McMurray John J.V.²

Affiliation:

1. National Institute of Health and Medical Research, Centre for Clinical Multidisciplinary Research, INSERM U1116 University of Lorraine, Regional University Hospital of Nancy, French Clinical Research Infrastructure Network Investigation Network Initiative‐Cardiovascular and Renal Clinical Trialists Nancy France

2. British Heart Foundation Cardiovascular Research Centre University of Glasgow Glasgow UK

3. Department of Cardiology, Rigshospitalet Copenhagen University Hospital Copenhagen Denmark

4. Cardiovascular Division Brigham and Women's Hospital Boston MA USA

5. Montreal Heart Institute Montreal QC Canada

6. Medical University of South Carolina and Ralph H. Johnson Department of Veterans Affairs Medical Center Charleston SC USA

7. Baylor Heart and Vascular Institute Baylor University Medical Center Dallas TX USA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.1987

Reference30 articles.

1. Managing Hyperkalemia Caused by Inhibitors of the Renin–Angiotensin–Aldosterone System

2. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

3. 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure

4. Potassium binders for the prevention of hyperkalaemia in heart failure patients: implementation issues and future developments

5. Association of Serum Potassium with All-Cause Mortality in Patients with and without Heart Failure, Chronic Kidney Disease, and/or Diabetes

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potassium levels and the risk of all-cause and cardiovascular mortality among patients with cardiovascular diseases: a meta-analysis of cohort studies;Nutrition Journal;2024-01-10

2. Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists;Diabetologia;2023-12-21

3. Biomarkers in predicting mortality from cardiovascular events in patients with heart failure and an implanted cardioverter-defibrillator;Rational Pharmacotherapy in Cardiology;2023-09-29

4. Practical patient care appraisals with use of new potassium binders in heart failure and chronic kidney diseases;Journal of Cardiovascular Medicine;2023-08-30

5. Detailed safety analysis of DIAMOND trial: ‘primum non nocere’?;European Heart Journal;2023-08-16